Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
121 HLA-B* 15 predicts survival in Egyptian patients with COVID-19 Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2021
122 Expression of programmed death ligand-1 (PDL-1) in Acute Myeloid Leukemia Patients and its relation to post induction Department of Clinical Pathology Lamyaa Ahmed Abdelhafeez Ahmed 2021
123 Bendamustine in Refractory / Relapsed Non Hodgkin Lymphoma Department of Medical Oncology Dr. Maged Abdelfatah Amine Hassan 2021
124 Prognostic value of CD10, BCL6 and MUM1 in diffuse large B-cell lymphoma Department of Pathology Saly Salah Abdelhakeem 2021
125 Association of robust radiomic features from staging18F-FDG PET/CT in lung cancer with EGFR over expression and overall survival Department of Radiotherapy and Nuclear medicine Dr. Yasser Gaber Ali Abdelhafez 2021
126 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021
127 Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt Department of Pediatric Oncology Prof. Amany Mohamed Ali Ahmed 2021
128 Concurrent capecitabine with external beam radiotherapy versus radiotherapy alone in painful bone metastasis of breast cancer origin Department of Radiotherapy and Nuclear medicine Dr. Ayat allah Ali yousseif 2021
129 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Department of Clinical Pathology Dr. Mohamed Galal Mostafa ELnaggar 2021
130 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Department of Medical Oncology Dr. Ahmed Mubarak Hefni Ismail 2021